Zydus Lifesciences will consider raising up to ₹5,000 crore via multiple routes, including QIP and rights issue, as it prepares to announce its Q2 results.

Revenue from operations grew 7.4% year-on-year to ₹1,012.8 crore against ₹942.6 crore in the year-ago period, according to the company’s exchange filing. Operating performance improved…

In its earlier plan, PRISM had proposed one bonus share for every 6,000 equity shares held, linked to a potential IPO pathway for OYO. However,…

All seven companies, which filed their preliminary IPO papers with Sebi between May and July, obtained its observations during October 14 to 31, the update…

Godfrey Phillips India posted a 22.9% YoY rise in Q2FY26 net profit to ₹305 crore, driven by higher margins. The company announced an interim dividend…

Shares of City Union Bank closed 3% higher ahead of the results, at a price of ₹235.90 on the BSE today. The stock has gained…

For the quarter ended September 30, 2025 (Q2 FY26), the company’s net profit rose more than five times to ₹264 crore, compared to ₹52 crore…

Kirloskar Brothers reported a 25.8% YoY decline in Q2FY26 profit to ₹71 crore, with margins under pressure. Shares of the company ended higher on Monday,…

Going ahead, markets are likely to track the ongoing earnings season, while any positive trigger on the India-US trade deal front could lift sentiment.

For H1 FY26, the company recorded bookings of ₹607 crore, slightly lower than ₹666 crore in H1 FY25, while collections stood at ₹427 crore compared…